Co-Diagnostics, Inc. (CODX)
1.265
+0.02
(+1.20%)
USD |
NASDAQ |
Aug 27, 16:00
1.26
0.00 (0.00%)
After-Hours: 18:20
Co-Diagnostics Shareholders Equity (Quarterly) : 12.71M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.71M |
| March 31, 2026 | 16.04M |
| December 31, 2025 | 20.63M |
| September 30, 2025 | 39.83M |
| June 30, 2025 | 41.14M |
| March 31, 2025 | 47.92M |
| December 31, 2024 | 53.88M |
| September 30, 2024 | 63.78M |
| June 30, 2024 | 72.40M |
| March 31, 2024 | 78.35M |
| December 31, 2023 | 86.01M |
| September 30, 2023 | 99.49M |
| June 30, 2023 | 103.43M |
| March 31, 2023 | 110.63M |
| December 31, 2022 | 114.52M |
| September 30, 2022 | 134.95M |
| June 30, 2022 | 144.47M |
| March 31, 2022 | 147.71M |
| December 31, 2021 | 134.48M |
| September 30, 2021 | 100.16M |
| June 30, 2021 | 87.27M |
| March 31, 2021 | 76.26M |
| Date | Value |
|---|---|
| December 31, 2020 | 66.70M |
| September 30, 2020 | 52.78M |
| June 30, 2020 | 35.73M |
| March 31, 2020 | 19.17M |
| December 31, 2019 | 1.737M |
| September 30, 2019 | 3.334M |
| June 30, 2019 | 4.806M |
| March 31, 2019 | 5.564M |
| December 31, 2018 | -1.059M |
| September 30, 2018 | 0.1274M |
| June 30, 2018 | 1.243M |
| March 31, 2018 | 2.565M |
| December 31, 2017 | 3.850M |
| September 30, 2017 | 5.189M |
| June 30, 2017 | -4.395M |
| March 31, 2017 | -3.694M |
| December 31, 2016 | -2.995M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -1.147M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Fractyl Health, Inc. | -1.665M |
| Spectral AI, Inc. | -12.05M |
| Quantum-Si, Inc. | 180.20M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Omnicell, Inc. | 1.292B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.59M |
| Total Liabilities (Quarterly) | 3.878M |
| Debt to Equity Ratio | 0.1415 |
| Current Ratio | 1.813 |
| Net Debt Paydown Yield | 0.17% |